Tag: ANDA litigation

The Federal Circuit Court holds exclusive authority over U.S. pharmaceutical patent cases, shaping drug availability, pricing, and innovation. Its rulings on ANDA litigation, dosing patents, and Orange Book listings directly impact generic drug entry and patient access.